<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epidemiological data collected over the last few decades have demonstrated the significant role of <z:hpo ids='HP_0011009'>acute</z:hpo> (especially postprandial) <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> in the development of macrovascular complications in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the influence of SUR1 exon 16-3c/t polymorphism on <z:e sem="disease" ids="C0948379" disease_type="Disease or Syndrome" abbrv="">impaired insulin secretion</z:e> during <z:hpo ids='HP_0011009'>acute</z:hpo> hyperglycaemic episodes has not yet been evaluated </plain></SENT>
<SENT sid="2" pm="."><plain>We studied 40 type 2 diabetic patients </plain></SENT>
<SENT sid="3" pm="."><plain>Single nucleotide polymorphism in the <z:chebi fb="0" ids="26831">sulfonylurea</z:chebi> receptor gene was examined by means of PCR-RLFP </plain></SENT>
<SENT sid="4" pm="."><plain>In every patient, fasting insulin, proinsulin, C-<z:chebi fb="7" ids="16670">peptide</z:chebi> and 1,5-anhydro-d-<z:chebi fb="0" ids="30911">glucitol</z:chebi> concentrations were assayed as markers of insulin secretion, peripheral resistance to insulin, and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The distribution of SUR1 exon 16-3c/t polymorphism was tt 35%, tc -40%, and cc -25% </plain></SENT>
<SENT sid="6" pm="."><plain>By means of analysis of covariance, it was revealed that 1,5-anhydro-d-<z:chebi fb="0" ids="30911">glucitol</z:chebi> plasma levels are associated with SUR1 exon 16-3c/t polymorphism </plain></SENT>
<SENT sid="7" pm="."><plain>However, the HOMA(IR) score influenced 1,5-anhydro-d-<z:chebi fb="0" ids="30911">glucitol</z:chebi> levels in plasma at a higher level of statistical power than the genetic variant </plain></SENT>
<SENT sid="8" pm="."><plain>Our results suggest that SUR1 exon 16-3c/t polymorphism is only a partial determinant of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e>-<z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factor</z:e> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>